- Home
- UBX vs MMA Comparison
UBX vs MMA Comparison
Compare UBX & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- MMA
- Stock Information
- Founded
- UBX 2009
- MMA 2013
- Country
- UBX United States
- MMA Australia
- Employees
- UBX N/A
- MMA N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- MMA
- Sector
- UBX Health Care
- MMA
- Exchange
- UBX Nasdaq
- MMA Nasdaq
- Market Cap
- UBX 13.9M
- MMA 13.4M
- IPO Year
- UBX 2018
- MMA 2024
- Fundamental
- Price
- UBX $0.78
- MMA $1.40
- Analyst Decision
- UBX Strong Buy
- MMA
- Analyst Count
- UBX 3
- MMA 0
- Target Price
- UBX $4.67
- MMA N/A
- AVG Volume (30 Days)
- UBX 521.0K
- MMA 426.1K
- Earning Date
- UBX 08-05-2025
- MMA 01-21-2025
- Dividend Yield
- UBX N/A
- MMA N/A
- EPS Growth
- UBX N/A
- MMA N/A
- EPS
- UBX N/A
- MMA N/A
- Revenue
- UBX N/A
- MMA $407,412.00
- Revenue This Year
- UBX N/A
- MMA N/A
- Revenue Next Year
- UBX N/A
- MMA N/A
- P/E Ratio
- UBX N/A
- MMA N/A
- Revenue Growth
- UBX N/A
- MMA N/A
- 52 Week Low
- UBX $0.66
- MMA $0.60
- 52 Week High
- UBX $3.10
- MMA $4.11
- Technical
- Relative Strength Index (RSI)
- UBX 48.12
- MMA N/A
- Support Level
- UBX $0.67
- MMA N/A
- Resistance Level
- UBX $0.83
- MMA N/A
- Average True Range (ATR)
- UBX 0.09
- MMA 0.00
- MACD
- UBX 0.01
- MMA 0.00
- Stochastic Oscillator
- UBX 24.67
- MMA 0.00
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.